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Molecular Diversity and Potential 
Anti-neuroinflammatory Activities 
of Cyathane Diterpenoids from the 
Basidiomycete Cyathus africanus
Jing Wei1, Yuanyuan Cheng2, Wan-Hui Guo1, Da-Cheng Wang1, Qiang Zhang1, Ding Li1,  
Jianhui Rong2 & Jin-Ming Gao1
Ten new polyoxygenated cyathane diterpenoids, named neocyathins A–J (1–10), together with four 
known diterpenes (11–14), were isolated from the liquid culture of the medicinal basidiomycete 
fungus Cyathus africanus. The structures and configurations of these new compounds were elucidated 
through comprehensive spectroscopic analyses including 1D NMR, 2D NMR (HSQC, HMBC, NOESY) 
and HRESIMS, and electronic circular dichroism (ECD) data. Neuroinflammation is implicated in the 
pathogenesis of various neurodegenerative diseases, such as Alzheimers’ disease (AD). All isolated 
compounds were evaluated for the potential anti-neuroinflammatory activities in BV2 microglia cells. 
Several compounds showed differential effects on the expression of inducible nitric oxide synthase 
(iNOS) and cyclooxygenase-2 (COX-2) in lipopolysaccharide (LPS)-stimulated and Aβ1–42-treated 
mouse microglia cell line BV-2. Molecular docking revealed that bioactive compounds (e.g., 11) could 
interact with iNOS protein other than COX-2 protein. Collectively, our results suggested that this 
class of cyathane diterpenoids might serve as important lead compounds for drug discovery against 
neuroinflammation in AD.
Neuroinflammation is implicated in the pathogenesis of various neurodegenerative diseases including 
Alzheimer’s disease(AD)1, 2. Microglia are the resident immune cells in the central nervous system (CNS). It 
is well-known that microglia are often activated by different stimuli to mediate inflammatory responses in the 
brain, suggesting the importance of microglial inhibition against neuroinflammation and neurodegeneration3. 
Lipopolysaccharide (LPS) and amyloid-β (Aβ) could activate microglia and subsequently induce inducible oxide 
synthase (iNOS) and cyclooxygenase-2 (COX-2)4, 5. Excessive NO production directly causes neuronal injury and 
even neuronal death3. Thus, neuroinflammation may be a potential therapeutic target for treating AD and other 
neurodegenerative diseases.
Basidiomycetes are known to produce a broad spectrum of secondary metabolites. A number of cyathane dit-
erpenoids with an unusual 5/6/7 tricyclic skeleton, including their xylosides, were isolated from a diverse variety 
of higher Basidiomycetes of the genera Cyathus, Hericium, and Sarcodon6–8. These diterpenes were demonstrated 
to display a wide range of biological properties, including anti-inflammatory9, antimicrobial10 antitumor11 and 
antagonism toward the kappa-opioid receptor12. Several cyathane diterpenoids were found to stimulate the syn-
thesis of NGF in human nerve cells8, 13, 14 indicating their potential as therapeutic agents to treat neurodegener-
ative ailment.
The fungi Cyathus is a genus in the family of Nidulariaceae, collectively known as the bird’s nest fungi. These 
fungi are widely distributed all over the world, and usually grow on decaying wood/woody debris and cow/horse 
dung. Although generally inedible, Cyathus species is well known as the prolific producers of bioactive cyathane 
diterpenoids.
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We have been vigorously searching for novel bioactive compounds from basidiomycete fungi11, 15–19. The aim 
of the present study was to identify new cyathane diterpenoids against neuroinflammation. We isolated a total 
of 14 compounds and elucidated the structures by NMR, HRESIMS, and ECD analyses. All isolated compounds 
were evaluated for the anti-neuroinflammatory effects in lipopolysaccharide (LPS)- or Aβ1–42-stimulated mouse 
microglia cell line BV-2.
Results and Discussion
Structure elucidation. The culture broth of Cyathus africanus was extracted with EtOAc and subjected to 
a series of chromatographic separations. Among a total of 14 compounds isolated, there were 10 new diterpenes, 
named neocyathins A–J (1–10) and four known congeners (11–14) (Fig. 1). The compounds (11–14) were iden-
tified as cyathin I (11)20 (12R)-11α,14α-epoxy-13α,14β,15-trihydroxycyath-3-ene (12)21 cyathin O (13)22 and 
allocyafrin B4 (14)23 respectively, by comparing their NMR data with those reported in literatures.
Compound 1 was isolated as a white powder. The molecular formula of 1 was determined to be C20H28O5, 
with seven degrees of unsaturation, on the basis of HRESIMS at m/z 371.1824 [M + Na]+. The 1H NMR spectrum 
(Table 1) revealed the presence of four methyls [δH 1.09 (3H, s, H3-17), 1.15 (3H, s, H3-16), 1.26 (3H, d, J = 6.7 Hz, 
H3-19), 1.37 (3H, d, J = 6.7 Hz, H3-20)], two olefinic protons [δH 5.96 (1H, s, H-2), 6.11 (1H, s, H-13)], one oxym-
ethine [δH 4.24 (1H, m, H-11)], and two oxymethylene protons [δH 4.26 (1H, d, J = 15.6 Hz, H-15), 4.42 (1H, d, 
J = 15.6 Hz, H-15)]. The 13C NMR data (Table 2) revealed 20 carbon signals corresponding to four methyls, four 
Figure 1. Structures of isolated compounds 1–14.
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methylenes (one oxygenated at δC 64.4 (C-15)), five methines [one oxygenated at δC 73.0 (C-11), two olefinic at δC 
127.0 (C-2) and 122.6 (C-13)], and seven quaternary carbons [one oxygenated at δC 84.0 (C-4), two olefinic and 
two carbonyl).
Compound 1 showed similar NMR spectroscopic profile to that of allocyafrin B4 (14). The key difference 
between compound 1 and allocyafrin B4 (14) was the replacement of the methine at C-4 (δC 56.2) by an oxy-
genated quaternary carbon (δC 84.0), suggesting a hydroxy group at C-4. Such prediction was supported by the 
HMBC correlations from H-17 to C-1, C-4, from H-2 to C-1, C-3, C-4, C-9, and from H-5, H-10 to C-4 (Fig. 2). 
These two compounds exhibited different chemical shifts of C-17 and C-5. The γ-effect of the hydroxy groups 
drove C-4 and C-17 in 1 to resonate at higher fields (14.5 ppm vs21.4 ppm), whereas the β-effect downshielded 
C-5 from 43.7 ppm to 37.8 ppm. As previously observed in cyrneine C and cyrneine D, two homologous cyathane 
diterpene derivatives from the fungus Sarcodon cyrneus24 the methyl group at C-16 was upshifted by 3.6 ppm with 
respect to 14 (17.4 ppm vs 21.0 ppm).
The relative configuration of the hydroxy group at C-4 of 1was determined through a NOESY experiment 
in DMSO-d6. The key cross-peak of H-5/4-OH in the NOESY spectrum indicated the relative β-configuration 
for 4-OH in 1 (Fig. 3). Thus, all these data allowed us to establish compound 1 as 4β-hydroxyallocyafrin B4, and 
named neocyathin A.
Compound 2 was isolated as a white solid. The molecular formula of 2 was determined to be C20H30O4 on 
the basis of HRESIMS at m/z 357.2034 [M + Na]+, with six degrees of unsaturation. The IR strong absorptions at 
1684 cm−1 and UV absorption maxima at 243 nm of 2 indicated the presence of hydroxyl and α, β-unsaturated 
ketone functionality. The 1H NMR spectrum (Table 1) revealed the presence of four methyls [δH 0.88 (3H, s, H3-
16), 1.20 (3H, d, J = 6.9 Hz, H3-20), 1.21 (3H, d, J = 6.9 Hz, H3-19), 1.26 (3H, s, H3-17)], one olefinic proton [δH 
5.75 (1H, d, J = 6.2 Hz, H-13)], two oxymethines [δH 4.08 (1H, d, J = 6.2 Hz, H-14), 4.67 (1H, m, H-11)], and two 
oxymethylene protons [δH 4.17 (2H, s, H2-15)]. The 13C NMR data (Table 2) displayed 20 carbon resonances cor-
responding to four methyls, five methylenes [(one oxygenated at δC 65.0 (C-15)], five methines [two oxygenated 
at δC 71.6 (C-11) and 76.2 (C-14), one olefinic at δC 127.3 (C-13)], and six quaternary carbons [three olefinic and 
one carbonyl]. The NMR spectroscopic data of 2 were similar to those of cyathatriol7 except for the presence of a 
ketonic carbonyl group at C-2 (δC 211.1).
The structure of 2 was established through further analysis involving 1D NMR, HMBC and COSY spectra. 
The 1H-1H-COSY and HMBC spectra of 2 allowed the identification of four partial structures (Fig. 2), CH3-19/
CH-18/CH3-20, CH-5/CH2-10/CH-11, CH-13/CH-14 and CH2-7/CH2-8. The planar structure for 2 was deter-
mined based on the key HMBC correlations from H-19 and H-20 to C-3, from H-18 to C-2, from H-17 to C-1, 
C-4, C-8, C-9, from H-1 to C-2, C-3, C-4, C-8, C-9, C-17, from H-16 to C-5, C-6, C-7, C-14, and from H-13 to 
C-6, C-11, C-14, C-15 as shown in Fig. 2.
The NOESY experiment was performed to determine the relative configuration for compound 2. The NOESY 
spectrum revealed the key cross-peaks of H-5/H-11, H-5/17-Me, H-7a/17-Me and H-7b/H-14, indicating the 
5R*, 6R*, 9S*, 11R*, 14S* configuration for compound 2 (Fig. 3).
To confirm the absolute configuration of 2, we measured its electronic CD spectrum in acetonitrile (Fig. 4). 
The experimental curve of 2 showed the positive Cotton effects (CEs) at 206 nm (Δε + 43.4) and the negative 
CEs at 242 (Δε − 17.7) and 320 nm (Δε − 5.61). Consistently, the time-dependent density functional theory 
No. 1a 2b 3b 4b 5b 6b 7b 8b 9b 10b
1 2.16 d (18.9)  2.14 d (18.9) 3.68 d (5.2)
1.50 m 
1.47 m 3.79 dd (9.5 8.0) 3.75 s 3.59 d (6.9)
2.17 d (18.8) 2.16 
d (18.8)
2 5.96 s 4.56 d (5.2) 4.37 m 2.44 dd (14.7 8.0) 2.09 m 4.46 d (6.9) 5.89 s 5.91 s
4 2.79 m 2.76 dd (5.2, 1.8)
5 2.21 d (6.3) 3.16 d (10.4) 2.72 d (7.9) 2.61 d (8.8) 2.51 m 3.03 dd (12.6, 4.1) 2.57 m 2.44 m 2.07 m 2.77 dd (12.8, 3.8)
7 1.69 m1.47 m 1.99 m 1.31 m 1.71 m 1.41 m
1.72 m 
1.41 m 1.56 m 1.36 m 1.70 m 1.55 m
1.56 m 1.41 
td (12.5, 4.1)
1.70 m 
1.45 m 1.64 m 1.39 m 1.73 m 1.59 m





1.66 m 1.49  
td (13.5, 4.5) 1.87 m 1.75 m 1.63 m 1.49 m
1.80 m 
1.38 m 2.28 m 1.45 m 1.83 m 1.66 m
10
2.87 dd (12.6, 5.3) 
1.76 ddd (12.6, 
10.8, 7.3)
2.21 m 1.63 m 2.52 m 1.93 m
2.34 m 
1.51 m 2.16 m 1.59 m






1.87 m 1.79 m 1.41 m 2.38 m 1.56 m
11 4.24 m 4.67 m 4.17 m 4.11 m 4.68 m 4.74 m 4.68 s 4.26 m 4.22 m 4.23 m
12 2.34 m 2.33 m
13 6.11 s 5.75 d (6.2) 6.12 s 6.12 d (1.6) 5.99 s 6.07 s 5.99 3.66 s 4.28 d (7.7) 4.49 d (7.8)
14 4.08 d (6.2)
15 4.42 d (15.6)  4.26 d (15.6) 4.17 s
4.38 d (15.6) 
4.27 d (15.6)
4.33 m 4.25 
d (15.9) 4.23 2 H m
4.30 d (15.4)  
4.23 d (15.4)
4.27 d (16.5) 
4.21 d (16.5)
4.10 d (13.3) 
3.85 d (13.3)
3.82 dd (10.9, 5.8) 
3.57 dd (10.9, 8.8)
3.84 dd (10.9, 5.9) 
3.60 dd (10.9, 8.7)
16 1.15 s 0.88 s 1.09 1.42 s 0.99 s 1.05 s 1.06 s 0.98 s 1.01 s 1.06 s
17 1.09 s 1.26 s 1.13 0.98 s 0.90 s 1.08 s 0.93 s 1.17 s 1.13 s 1.27 s
18 2.80 m 3.05 m 2.85 m 2.14 m 2.95 m 3.10 m 2.99 m 2.93 m 2.91 m 3.05 m
19 1.26 d (6.7) 1.21 d (6.9) 1.23 d (6.6) 1.18 d (6.9) 0.89 d (6.8) 1.18 d (6.9) 1.10 d (7.1) 1.18 d (6.5) 1.26 d (6.5) 1.17 d (7.0)
20 1.37 d (6.7) 1.20 d (6.9) 1.16 d (6.6) 1.32 d (6.9) 1.01 d (6.8) 1.17 d (6.9) 1.20 d (7.1) 1.27 d (6.5) 1.16 d (7.0) 1.20 d (7.0)
Table 1. 1H NMR Spectroscopic Data for Compounds 1–10 in MeOH-d4. a800 MHz. b500 MHz.
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No. 1a 2b 3b 4b 5b 6b 7b 8b 9b 10b
1 213.7 53.1 88.5 47.0 82.8 84.5 90.5 215.4 216.0 53.3
2 127.0 211.1 83.5 72.8 37.2 209.5 83.3 125.8 126.4 210.9
3 188.5 144.2 140.2 77.8 137.2 141.6 139.6 192.3 193.2 144.9
4 84.0 181.7 141.4 78.2 137.8 174.0 140.1 53.3 53.5 177.0
5 43.7 43.2 39.0 37.1 41.6 43.3 41.3 38.9 37.5 40.5
6 52.9 45.8 56.6 54.6 42.6 44.9 42.8 42.7 41.9 46.0
7 33.1 32.0 34.8 34.7 31.0 30.5 30.9 29.7 29.9 29.7
8 34.5 39.3 30.2 33.7 36.2 35.3 36.1 30.3 30.8 37.1
9 54.0 43.5 48.7 42.6 49.9 47.3 47.2 50.2 50.4 42.9
10 34.8 36.6 37.0 32.3 28.3 27.6 28.2 29.9 33.3 31.5
11 73.0 71.6 72.4 72.3 80.0 79.9 79.9 74.6 76.9 76.3
12 157.5 145.9 157.0 157.3 149.0 149.2 149.2 64.0 49.7 49.8
13 122.6 127.3 123.2 123.2 126.6 126.9 126.6 57.0 70.6 70.2
14 209.7 76.2 210.6 210.1 111.2 110.8 111.1 104.8 108.2 107.4
15 64.4 65.0 64.5 64.4 58.9 58.9 58.9 59.1 62.1 62.0
16 17.4 17.1 15.6 17.9 12.0 12.2 12.2 14.6 16.1 13.2
17 14.5 24.3 23.6 20.7 17.3 22.4 19.6 20.5 22.4 26.0
18 31.2 26.7 28.2 29.8 27.5 26.3 27.2 33.0 33.0 26.2
19 22.2 21.0 24.3 20.5 21.2 20.2 19.3 23.4 21.0 20.5
20 25.3 20.1 19.6 20.4 22.6 21.2 24.6 21.0 23.3 20.6
Table 2. 13C NMR Spectroscopic Data for Compounds 1–10 in MeOH-d4. a200 MHz. b125 MHz.
Figure 2. Key COSY and HMBC correlations of compounds 1–10.
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(TDDFT) method (cam-B3LYP/TZVP) provided similar calculated ECD values, thereby implying its absolute 
configuration to be 5R, 6R, 9S, 11R, 14S. Accordingly, the structure of 2 was established as shown, and named 
neocyathin B.
Compound 3 was isolated as a yellow oil. The molecular formula of 3 was determined to be C20H30O5 based 
on the HRESIMS at m/z 373.1980 [M + Na]+. The 13C NMR data (Table 2) revealed 20 carbon resonances, cor-
responding to four methyls (two singlets and two doublets), four methylenes (one oxygenated), six methines 
(three oxygenated and one olefinic), and six quaternary carbons (three olefinic and one carbonyl). The NMR 
spectroscopic data of 3 were similar to those of allocyafrin B4 (14). The main differences between 3 and 14 were 
the presence of two hydroxy groups at C-1 (δC 88.5) and C-2 (δC 83.5) and an olefinic bond at C-3 (δC 140.2) and 
C-4 (δC 141.4) in 3. These observations were supported by the HMBC correlations from H-17 to C-1, C-4, from 
H-19 and H-20 to C-3, from H-10 to C-4, from H-5 and H-10 to C-4, C-3, from H-1 to C-2, C-3, and from H-2 to 
C-3 (Fig. 2). Further analysis of the HMBC and COSY spectra allowed the structural establishment of 3. From the 
COSY spectrum, a CH-5/CH2-10/CH-11 and CH2-7/CH2-8 were established. The key HMBC correlations from 
H-17 to C-1, C-4, C-8, C-9, from H-1 to C-2, C-3, C-8, C-9, C-17, from H-16 to C-5, C-6, C-7, C-14, and from 
H-13 to C-6, C-11, C-12, C-15 (Fig. 2). Hence, the planar structure of 3 was elucidated as shown.
The relative configuration of 3 was determined through a NOESY experiment. The key cross-peaks of H-5/H-
11, H-5/17-Me, H-8a/16-Me, H-8a/H-1 and H-8a/H-2 in the NOESY spectrum indicated the relative configura-
tion of 3 was (1S*, 2R*, 5R*, 6R*, 9R*, 11R*) (Fig. 3). The experimental ECD spectrum of compound 3 matched 
Figure 3. The conformation of 1–10 with minimized energy. The arrows show the key NOESY correlations.
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well with calculated ECD spectrum of (1S, 2R, 5R, 6R, 9R, 11R)-3 (Fig. 4). Thus, the structure and absolute con-
figuration of 3 were established as shown, and named neocyathin C.
Compound 4 was isolated as a white powder. The molecular formula of 4 was determined to be C20H30O5, 
with six degrees of unsaturation, based on the HRESIMS at m/z 373.1979 [M + Na]+. The 1H NMR spectrum 
(Table 1) revealed the presence of four methyls [δH 0.98 (3H, s, H3-17), 1.18 (3H, d, J = 6.9 Hz, H3-19), 1.32 (3H, d, 
J = 6.9 Hz, H3-20), 1.42 (3H, s, H3-16)], one olefinic proton [δH 6.12 (1H, d, J = 1.6 Hz, H-13)], two oxymethines 
[δH 4.11 (1H, m, H-11), 4.37 (1H, m, H-2)], and two oxymethylene protons [δH 4.25 (1H, d, J = 15.9 Hz, H-15), 
4.33 (1H, m, H-15)]. The 13C NMR data (Table 2) revealed 20 carbon resonances, corresponding to four methyls 
(two singlets and two doublets), five methylenes (one oxygenated), five methines (two oxygenated at δC 72.3 and 
72.8 and one olefinic at δC 123.2), and six quaternary carbons (two oxygenated at δC 77.8 and 78.2, one olefinic 
δC 157.3, and one carbonyl at δC 210.1). The 1H-1H COSY spectrum of 4 showed the spin system of CH3-19/
CH-18/CH3-20, CH2-1/CH-2, CH-5/CH2-10/CH-11 and CH2-7/CH2-8. In the HMBC spectrum of 4, the HMBC 
correlations from H-2 to C-4, C-9, from H-5 to C-4, from H-10 to C-4, C-6, C-11 and C-12, from H-13 to C-6, 
C-11, C-12 and C-15, from H3-16 to C-5, C-6, C-7, and C-14, from H3-17 to C-1, C-4, C-8, and C-9, and from 
H3-19(20) to C-3, C-18 completed the structure of the cyathane diterpenoid skeleton (Fig. 2). The chemical shift 
for C-3 (δC 77.8) and C-4 (δC 78.2), together with the degree of unsaturation requirement, suggested the epoxy 
bridge between C-3 and C-4. Detailed analysis of the 1D NMR together with the HMBC and COSY data revealed 
the main differences between compounds 4 and 3 were the presence of an additional epoxy bridge between C-3 
and C-4 instead of a double bond, and the absence of the hydroxy group at C-1 (δC 47.0) in 4. This deduction was 
supported by the HMBC correlations from H-17 to C-1, C-4, from H-19 and H-20 to C-3, from H-5 and H-10 to 
C-4, and from H-2 to C-4, C-9 (Fig. 2).
The relative configurations of the epoxide group and the hydroxy group at C-2 of 4 were assigned by NOESY 
experiments. The cross-peaks of H-2/19-Me and H-18/16-Me in the NOESY spectrum confirmed all β orienta-
tion of the epoxy bridge and the hydroxy group at C-2 (Fig. 3). Thus, the structure of 4 was established as shown, 
and named neocyathin D.
Compound 5 was isolated as a white powder. The molecular formula of 5 was determined to be C20H30O4, 
with six degrees of unsaturation, based on the HRESIMS at m/z 357.2032 [M + Na]+. The 13C NMR data (Table 2) 
revealed 20 carbon resonances, inculding four methyls, five methylenes (one oxygenated), five methines (two 
oxygenated and one olefinic at δC 126.6), and six quaternary carbons (three olefinic at δC 137.2, 137.8, 149.0 and 
a ketal carbon at δC 111.2). The chemical shifts for C-11 (δC 80.0) and C-14 (δC 111.2) together with the degree of 
unsaturation requirement supported the existence of an epoxy bridge between C-11 and C-14, which was implied 
by HMBC correlation of H-11 (δH 4.68) with C-14.
The 1H-1H-COSY and HMBC spectra of 5 allowed the identification of four partial structures, CH3-19/
CH-18/CH3-20, CH-1/CH2-2, CH-5/CH2-10/CH-11 and CH2-7/CH2-8 (Fig. 2). The connectivity of each partial 
structure was clarified by the HMBC spectrum as shown in Fig. 2. The key HMBC correlations observed from 
H-20 to C-3, from H-18 to C-2, from H-17 to C-1, C-4, C-8, C-9, from H-2 to C-3, C-4, C-9, from H-16 to C-5, 
Figure 4. Experimental and theoretical ECD spectra of 2, 3, 5 and 8.
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C-6, C-7, C-14, from H-10 to C-5, C-12, from H-11 and H-13 to C-12, C-14, and from H-15 to C-12, C-13 indi-
cated that the planar cyathane structure of 5 was elucidated as shown.
The relative configuration of 5 was determined by NOESY experiments. The key NOE correlations of 
H-5/17-Me, H-8a/17-Me and H-8b/H-1 in the NOESY spectrum indicated the hydroxy group at C-1 of 5 was 
β-oriented (Fig. 3). The α stereochemistry of the epoxy bridge at C-11 and C-14 could not be clarified by the 
NOESY data. Compound 5 had a similar structure to the tautomeric internal hemiacetal 5a of cyathin A3, a 
metabolite of the bird’s nest fungus Cyathus helenae Brodie, except for the presence of the OH group at C-1 (δC 
82.8), whose absolute configuration had been unambiguously determined25, 26. Furthermore, the experimental 
ECD spectrum of compound 5 matched well with calculated ECD spectrum of (1R, 5R, 6R, 9R, 11R, 14R)-5 
(Fig. 4). Thus, the structure including absolute configuration of 5 was established as shown, and named neocy-
athin E.
The molecular formula of 6 was determined to be C20H28O5, with seven degrees of unsaturation, based on 
the HRESIMS at m/z 371.1825 [M + Na]+. The IR and UV spectra showed the presence of one α, β-unsaturated 
ketone moiety (IR ν 1696 cm−1; UV λmax 243 nm). The NMR spectroscopic data of 6 resembled those of 5 except 
for the presence of a ketonic carbonyl group at C-2 (δC 209.5), suggesting the α,β-unsaturated ketone unit [(δC 
209.5, 174.0 (C-4), 141.6 (C-3)] present in the molecule. This was supported by HMBC correlations of H-1 to C-2 
and C-4, H-19 and H-20 to C-3, and H-5 and H-17 to C-4 (Fig. 2). The unambiguous assignments of the signals 
in the 1H and 13C NMR spectra were based on the 2D-NMR (HMBC, HSQC, and COSY) experiments. The 
β-configuration of the hydroxy group at C-1 of 6 was determined by NOESY cross-peaks of H-1/H-7a, H-5/H-17, 
and H-7b/H-17 (Fig. 3). Thus, the structure of 6 was established as shown, and named neocyathin F.
The molecular formula of 7 was determined to be C20H30O5, with six degrees of unsaturation, based on the 
HRESIMS at m/z 373.1982 [M + Na]+. The 13C NMR/HSQC spectra (Table 1) of compound 1 indicated the 
presence of 20 carbon atoms and also revealed its close structural similarity to 5. Detailed analysis of the 1D 
NMR together with the HMBC and COSY data revealed the small differences between 7 and 5 were an additional 
hydroxy group at C-2 (δC 83.3), which were supported by the HMBC correlations from H-1 (δH 3.59) to C-2, and 
from H-2 (δH 4.46) to C-1 (δC 90.5), C-3 (δC 139.6) (Fig. 2).
The relative configuration of the hydroxy group at C-2 of 7 was determined through a NOESY experiment, 
in which the cross-peak of H-2/Me-17 indicated the OH group with α orientation (Fig. 3). The assignments of 
all proton and carbon signals were fully made by 2D (1H-1H COSY, HSQC, and HMBC) NMR data. Thus, the 
structure of 7 was established as shown, and named neocyathin G.
The molecular formula of 8 was determined to be C20H28O5, based on the HRESIMS at m/z 371.1825 
[M + Na]+, with seven degrees of unsaturation. The 1H NMR spectrum (Table 1) revealed the presence of four 
methyls [δH 0.98 (3H, s, H3-16), 1.17(3H, s, H3-17)], 1.18 (3H, d, J = 6.5 Hz, H3-19), 1.27 (3H, d, J = 6.5 Hz, H3-
20), one olefinic proton [δH 5.89 (1H, s, H-2)], two oxymethines [δH 3.66 (1H, s, H-13), 4.26 (1H, m, H-11)], and 
two oxymethylene protons [δH 3.85 (1H, d, J = 13.3 Hz, H-15), 4.10 (1H, d, J = 13.3 Hz, H-15)]. A comparison of 
the 13C NMR data between 8 and 14 (Table 2) suggested the presence of one α,β-unsaturated ketone moiety (δC 
125.8, 192.3, and 215.4; IR 1689 cm−1; UV 237 nm) in the molecule. This was supported by the HMBC correla-
tions of H-17/C-1, C-4, H-2/C-1, C-3, C-4, and C-9 (Fig. 2). Further comparison of the 13C NMR data between 
8 and 7 (Table 2) disclosed that the olefinic bond at C-12 (δC 149.2) and C-13 (δC 126.6) in 7 were replaced by an 
epoxy group at C-12 (δC 64.0) and C-13 (δC 57.0) in 8. This deduction was confirmed by the HMBC correlations 
of H-13/C-12, C-14, and H-15/C-12 (Fig. 2). The unambiguous assignments of the signals in the 1H and 13C NMR 
spectra were based on the 2D-NMR (HMBC, HSQC, and COSY) experiments (Fig. 2). Hence, the planar struc-
ture of 8 was elucidated as shown. Compound 8 was an analogue of cyafrin A5 with the epoxy group at C-12 and 
C-13, a metabolite of Cyathus africanus27.
The relative configuration of 8 was determined through a NOESY experiment. The key cross-peaks of 
H-5/17-Me, H-5/H-13 and H-4/17-Me in the NOESY spectrum indicated that the epoxy group at C-12 and C-13 
was α-oriented and that the relative configuration of 8 was (4R*, 5R*, 6R*, 9R*, 11R*, 12R*, 13R*, 14S*) (Fig. 3). 
Furthermore, the experimental ECD spectrum of 8 matched well with calculated ECD spectrum of (4R, 5R, 6R, 
9R, 11R, 12R, 13R, 14S)-8 (Fig. 4). Thus, the structure and absolute configuration of 8 was therefore determined 
as shown, and named neocyathin H.
The molecular formula of 9 was determined to be C20H30O5 based on the HRESIMS at m/z 373.1985 
[M + Na]+, with six degrees of unsaturation. The 13C NMR and HSQC spectra (Table 2) of 9 indicated the pres-
ence of 20 carbon atoms and also revealed its close structural similarity to 8. The major differences included the 
absence of an epoxide ring group between C-12 and C-13, and the appearance of an additional hydroxy group 
at C-13 (δC 70.6) in 9. The location of the OH group was supported by the HMBC correlations from H-15 (δH 
3.82, 3.57) to C-11 (δC 76.9), C-12 (δC 49.7), and from H-13 (δH 4.28) to C-11 (Fig. 2). The configuration of the 
hydroxymethyl at C-12 and the hydroxy group at C-13 (δC 70.6) in 9 was both assigned as α-form by NOESY 
experiments, in which the key correlations of H-5/H-12 and H-5/H-13 (Fig. 3). This deduction suggested that 9 
had the same relative configuration as that of cyathin I (11). Thus, the structure of 9 was established as shown, 
and named neocyathin I.
The molecular formula of 10 was determined to be C20H30O5 on the basis of the HRESIMS at m/z 373.1985 
[M + Na]+, identical to that of cyathin O (13)21. The 13C NMR data of 10 (Table 2) were very similar to those 
of 13 (Table S2). Detailed analysis of the 1D NMR together with the HMBC and COSY data revealed the main 
differences in chemical shifts of C-10 to C-15 between 10 and 13 were attributed to the α-configuration of a 
hydroxymethyl group at C-12 (δC 49.8) in 10 instead of the β-orientation of the corresponding hydroxymethyl at 
C-12 (δC 55.8) in 13 (Table S1, Supporting Information). The α-configuration was confirmed by NOESY exper-
iments, in which the key cross-peaks of H-5β (δH 2.77)/H-12 (δH 2.33) and H-5β/H-13 (δH 4.49) (Fig. 3). In 
addition, the chemical shifts of C-10 to C-15 in 10 closely resembled those of cyathin I (11) (Table S1, Supporting 
Information). Thus, the structure of 10 was established as shown, and named neocyathin J.
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Evaluation of the isolated compounds for regulating the expression and activity of iNOS and 
COX-2 in LPS-stimulated or Aβ1–42-treated BV2 cells. Microglial cells are inflammatory cells in 
the regulation of neurodegeneration28. To explore the biological activities of these cyathane diterpenoids, we 
firstly examined the cytotoxicity of the isolated compounds in BV2 microglial cells. As shown in Figure S63 
(Supporting Information), all compounds at the concentrations from 5 μM to 50 μM for 24 h did not show any 
toxicity. Following incubation of all compounds for 72 h, most of compounds exhibited no toxicity under indi-
cated concentrations, except for 4 and 6 at 50 μM with somewhat toxicity.
COX-2 and iNOS are two major inflammatory mediators in brain neurodegeneration29, 30. We subsequently 
examined the effects of all isolated compounds at the concentration of 50 μM on the expression of iNOS and 
COX-2 in LPS-stimulated BV2 microglial cells. As shown in Fig. 5, Western blot analysis demonstrated that 
compounds 2, 5, 11 and 13 significantly suppressed LPS-induced COX-2 expression, whereas compounds 4, 5, 7, 
8, 10, 11, 12, 13 and 14 markedly inhibited LPS-induced iNOS expression. Among these compounds, 5, 11 and 
13 showed strong inhibitory effects on both COX-2 and iNOS. Interestingly, 7, 12 and 14 abolished LPS-induced 
iNOS expression, but did not affect LPS-induced COX-2 expression. In addition, we also assayed the activities 
of iNOS enzyme. As shown in Fig. 6A, compounds 2, 3, 4, 5, 7, 8, 9, 10, 11, 12, 13 and 14 dramatically atten-
uated LPS-induced iNOS enzyme activities. The enzyme iNOS catalyzes the generation of nitric oxide (NO) 
from L-arginine oxidized upon stimulation31. Indeed, compounds 2, 5, 8, 12 and 13 significantly suppressed 
LPS-induced NO production in culture medium.
Neurotoxic peptide Aβ is well-known to induce iNOS and COX-2 expression and stimulate NO production in 
microglial cells4. Thus, we investigated all compounds for the anti-inflammatory effects on not only iNOS, COX-2 
expression but also NO production in Aβ1–42-treated BV2 cells. As shown in Fig. 7, compounds 1, 3, 6, 8, 9, 10, 11, 
12 and 13 inhibited COX-2 expression whereas compounds 2, 4, 5, 7, 8, 9, 10, 11, 12, 13 and 14 significantly sup-
pressed iNOS expression in Aβ1–42-stimulated BV2 cells. In addition, we examined the effects of all compounds 
on the production of NO. Consistent with previous study, compounds 2, 3, 4, 5, 7, 8, 9, 11, 12 and 13 markedly 
suppressed Aβ1–42-induced NO production. These results indicated that the bioactive compounds might exhibit 
anti-neuroinflammatory activities through inhibiting the expression and activity of pro-inflammatory enzymes 
(e.g., iNOS and COX-2).
To further elucidate the inhibitory effects of the bioactive diterpenoids on iNOS and COX-2, we performed 
molecular docking to understand the interaction of the active compounds 11 and 14 with iNOS and COX-2 
proteins as previously described32. Surprisingly, molecular docking studies revealed strong interactions between 
compounds 11 and 14 with iNOS protein (Fig. 8). Consistently, compounds 11 and 14 strongly inhibited iNOS 
enzyme activity. On the other hand, we also discovered that compound 11 could strongly interact with the COX-2 
protein. The logarithm of free binding energy and the binding residues were summarized in Table 3. Based on 
the results of molecular docking and activity assays, we postulated that this class of bioactive terpenoids (e.g., 
compound 11) might exhibit anti-inflammatory activities by binding to the active cavities of iNOS and COX-2.
Figure 5. Effects of isolated compounds on LPS-induced iNOS and COX-2 expression in BV2 microglia cells. 
(A) Western blot analysis of iNOS and COX-2 expression. The cells were pre-treated with all compounds with 
the concentration of 50 μM for 1 h, and subsequently incubated with 0.5 μg/mL of LPS for 24 h. The  
expression of iNOS and COX-2 was detected by Western blotting and quantified by Image Lab software.  
(B and C) Quantification of iNOS and COX-2 induction (Panel A). Data were expressed as mean ± SD (n = 3) 
and analyzed by one-way ANOVA with Dunnett’s test for iNOS expression and LSD test for COX-2 expression. 
*p < 0.05; **p < 0.01; ***p < 0.001. (Drug plus LPS vs LPS).
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Conclusion
In this study, we have isolated and fully characterized through extensive NMR spectroscopic analysis ten new 
cyathane-type diterpenoids (1–10) from the liquid culture of C. africanus. Interestingly, our results indicated that 
bioactive compounds might have anti-neuroinflammatory activities through the inhibition of pro-inflammatory 
enzymes expression and activities. Especially, compounds 11 and 14 strongly interact with the iNOS and COX-2 
proteins by targeting the residues near the active centers of iNOS and COX-2. Thus, we anticipate that the bioac-
tive components in C. africanus may be utilized for the development of anti-inflammatory agents against AD and 
related neurodegenerative disorders.
Methods
General experimental procedures. Optical rotations were recorded on an Autopol III automatic polar-
imeter (Rudolph Research Analytical). UV and IR spectra were obtained on a Thermo Scientific Evolution-300 
UV–visible spectrophotometer and a Bruker Tensor 27 FT-IR spectrometer with KBr pellets. ECD spectra were 
obtained on a Chirascan spectrometer. NMR spectra were obtained on Bruker Avance 800 MHz and Bruker 
Avance III 500 spectrometers with tetramethylsilane as an internal standard at room temperature. High-
resolution (HR) ESIMS were recorded on a Thermo Fisher Scientific Q-TOF mass spectrometer. Electrospray 
ionization mass spectrometry ESIMS were recorded on a Thermo Fisher LTQ Fleet instrument spectrometer. 
Silica gel (300–400 mesh, Qingdao Marine Chemical Ltd., People’s Republic of China) and RP- 18 gel (20–
45 μm, Fuji Silysia Chemical Ltd., Japan) were used for column chromatography (CC). Semipreparative HPLC 
was performed on a Waters 1525EF liquid chromatography system equipped with a Hypersil BDS C18 column 
(4.6 mm × 250 mm; 10.0 mm × 250 mm). Fractions were monitored by TLC. Compounds were visualized by heat-
ing silica gel plates immersed in 10% H2SO4 in ethanol.
Fungal material. The fungus Cyathus africanus was purchased from China General Microbiological Culture 
Collection Center (CGMCC) with the accession number CGMCC 5.1163. A specimen (No. CA20150728) was 
deposited at the College of Science, Northwest A&F University, Shaanxi, China. The culture medium consisted 
of glucose 2%, yeast extract 0.2%, peptone 0.5%, MgSO4 0.05%, KH2PO4 0.1%, with pH 6.5. Fermentation was 
carried out on a shaker at 130 rpm for 28 days at 28 °C.
Extraction and isolation. The culture broth (40 L) was filtered, and the filtrate was concentrated to 5 L, then 
extracted with ethyl acetate (5 L × 3), while the mycelium was extracted three times with CHCl3–MeOH (1:1). 
The EtOAc layer together with the mycelium extract was concentrated under reduced pressure to give a crude 
extract (30.2 g), and the latter was applied to a RP-18 column eluted with a gradient of MeOH–H2O (10–100%) to 
obtain six fractions, A–F. Fraction E was further purified by silica gel CC eluting with a gradient of CHCl3–MeOH 
(50:1–10:1), to yield five fractions (E1–E5). Fraction E2 was subjected to Sephadex LH-20 (MeOH) and further 
purified by semi-preparative HPLC (55%, MeOH–H2O, 2 mL/min) to yield 5 (tR = 13 min, 200 mg). Fraction 
E3 was subjected to Sephadex LH-20 (MeOH) and further purified by semi-preparative HPLC (90%, MeOH–
H2O, 2 mL/min) to yield 11 (tR = 9.0 min, 8 mg). Fraction E4 was subjected to Sephadex LH-20 (MeOH) and 
Figure 6. Effects of isolated compounds on iNOS enzyme activities and NO production in LPS-stimulated BV2 
microglia cells. (A) Assays of iNOS enzyme activities. BV2 cells were pre-treated with all compounds (50 μM) 
for 1 h, and stimulated with 0.5 μg/mL LPS for 24 h. The activities of iNOS enzyme were determined by using 
nitric oxide synthase activity assay kit (Abcam). The results were presented as mean ± SD (n = 3) and analyzed 
by one-way ANOVA with Dunnett’s test. *p < 0.05; **p < 0.01; ***p < 0.001. (Drug treatment plus LPS vs 
LPS). (B) Determination of NO levels in culture medium. After the drug treatment as previously described, 
the culture medium was collected for measurement of NO production by using Griess reagent kit for nitrite 
determination. Data were expressed as mean ± SD (n = 3) and analyzed by one-way ANOVA with Dunnett’s 
test. *p < 0.05; **p < 0.01; ***p < 0.001. (Drug plus LPS vs LPS).
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silica gel CC (CHCl3–MeOH, 20:1) to afford 12 (5.5 mg) and 10 (7.2 mg). Fraction D was further purified by 
silica gel CC eluting with a gradient of CHCl3–MeOH (50:1–10:1), to yield five fractions (D1–D5). Fraction 
D3 was subjected to Sephadex LH-20 (MeOH) and silica gel CC (CHCl3–MeOH, 20:1) and further purified by 
semi-preparative HPLC (39%, MeOH–H2O, 2 mL/min) to yield 14 (tR = 30.0 min, 6.0 mg). Fraction D4 was sub-
jected to Sephadex LH-20 (MeOH) and further purified by semi-preparative HPLC (60%, MeOH–H2O, 2 mL/
min) to yield 2 (tR = 12.5 min, 30.3 mg). Fraction D5 was subjected to Sephadex LH-20 (MeOH) and silica gel CC 
(CHCl3–MeOH, 30:1) and further purified by semi-preparative HPLC (40%, MeOH–H2O, 2 mL/min) to yield 4 
(tR = 11.0 min, 5.5 mg). Fraction C was further purified by silica gel CC eluting with a gradient of CHCl3–MeOH 
(50:1–10:1), to yield five fractions (C1–C5). Fraction C2 was subjected to Sephadex LH-20 (MeOH) to obtain 
two mixtures (C2.1 and C2.2). C2.1 was purified by semi-preparative HPLC (40%, MeOH–H2O, 2 mL/min) to 
yield 3 (tR = 12.0 min, 50.0 mg) and 7 (tR = 13.5 min, 4.2 mg). C2.2 was applied to silica gel CC (CHCl3–MeOH, 
40:1) to afford 6 (7.3 mg) and 9 (6.0 mg). Fraction B was further purified by silica gel CC eluting with a gradient 
of CHCl3–MeOH (50:1–10:1), to yield five fractions (B1–B5). Fraction B3 was subjected to Sephadex LH-20 
(MeOH) followed by purification with PTLC (petroleum–acetone 3:1, CHCl3–MeOH, 20:1) to yield compounds 
1 (6.0 mg), 13 (8.3 mg). Fraction B4 was subjected to Sephadex LH-20 (MeOH) and silica gel CC (CHCl3–MeOH, 
25:1) to afford 8 (5.4 mg).
Neocyathin A (1). White powder; [α]D25 = −49.3 (c = 0.24, MeOH); UV (MeOH) λmax (log ε): 230 (3.01), 300 
(2.23) nm; IR (KBr): νmax = 3436, 2966, 2103, 1690, 1456, 1380 cm−1; for 1H- and 13C- NMR data see Tables 1 and 
2, respectively; HR-ESI-MS: m/z 371.1824 [M + Na]+ (calcd. for C20H28O5Na, 371.1834).
Neocyathin B (2). White solid; [α]D25 = −34.3 (c = 0.08, MeOH); UV (MeOH) λmax (log ε): 204 (2.75), 243 
(2.92) nm; ECD: λ (c = 1.0 mg/mL, MeCN) (nm) (Δε) = 320 (−5.61), 242 (−17.7), 206 (+43.4); IR (KBr): 
νmax = 3401, 2926, 2863, 1684, 1374, 1215, 1031 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respectively; 
HR-ESI-MS: m/z 357.2034 [M + Na]+ (calcd. for C20H30O4Na, 357.2042).
Figure 7. Effects of isolated compounds on iNOS, COX-2 expression and NO production in Aβ1–42-treated BV2 
microglia cells. (A) Western blot analysis of iNOS and COX-2 expression. The cells were pre-treated with all 
compounds (50 μM) for 1 h, and subsequently incubated with 20 μM of Aβ1–42 for 24 h. The expression of iNOS 
and COX-2 was detected by Western blotting and quantified by Image Lab software. (B and C) Quantification 
of iNOS and COX-2 induction (Panel A). Data were expressed as mean ± SD (n = 3) and analyzed by one-way 
ANOVA with Dunnett’s test for iNOS expression and LSD test for COX-2 expression. *p < 0.05; **p < 0.01; 
***p < 0.001. (Drug plus Aβ1–42 vs Aβ1–42). (D) Determination of NO production in Aβ1–42-treated BV2 
microglia cells. BV2 cells were pretreated with all compounds (50 μM) for 1 h, and then stimulated with Aβ1–42 
(20 μM) for 6 h, the culture medium was collected for measurement of NO production by using Griess reagent 
kit for nitrite determination. Data were expressed as mean ± SD (n = 3) and analyzed by one-way ANOVA with 
LSD test. *p < 0.05; **p < 0.01; ***p < 0.001. (Drug plus Aβ1–42 vs Aβ1–42).
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Neocyathin C (3). Yellow oil; [α]D25 = −107.0 (c = 0.45, MeOH); UV (MeOH) λmax (log ε): 230 (2.74), 314 
(1.88) nm; ECD: λ (c = 1.0 mg/mL, MeCN) (nm) (Δε) = 391 (−0.39), 326 (+1.54), 206 (−22.7); IR (KBr): 
νmax = 3371, 2942, 2876, 1644, 1455, 1034 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respectively; 
HR-ESI-MS: m/z 373.1980 [M + Na]+ (calcd. for C20H30O5Na, 373.1991).
Neocyathin D (4). White powder; [α]D25 = −23.8 (c = 0.08, MeOH); UV (MeOH) λmax (log ε): 230 (3.20) nm; 
IR (KBr): νmax = 3416, 2938, 1641, 1446, 1381, 1028 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respec-
tively; HR-ESI-MS: m/z 373.1979 [M + Na]+ (calcd. for C20H30O5Na, 373.1991).
Figure 8. Molecular docking simulations of the binding of compounds 11 and 14 to iNOS and COX-2. Virtual 
drug-protein complexes including compounds 11 (A) and 14 (B) for iNOS, and 11 (C) for COX-2 were 
obtained at lowest energy conformation, while potential hydrogen contacts between compounds and proteins 
were highlighted by dashed lines. Atoms were colored as follows: carbon, cyan; nitrogen, blue; oxygen, red; 
hydrogen, gray; sulfur, orange.
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Neocyathin E (5). White powder; [α]D25 = −82.0 (c = 0.17, MeOH); UV (MeOH) λmax (log ε): 207 (2.68) 
nm; ECD: λ (c = 0.3 mg/mL, MeCN) (nm) (Δε) = 393 (−0.15), 327 (+0.32), 213 (−5.22); IR (KBr): νmax = 3451, 
2958, 2866, 2082, 1640, 1050 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respectively; HR-ESI-MS: m/z 
357.2032 [M + Na]+ (calcd. for C20H30O4Na, 357.2042).
Neocyathin F (6). White powder; [α]D25 = −77.9 (c = 0.19, MeOH); UV (MeOH) λmax (log ε): 206 (2.99), 243 
(3.07) nm; IR (KBr): νmax = 3374, 2939, 2872, 1696, 1384, 1031 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, 
respectively; HR-ESI-MS: m/z 371.1825 [M + Na]+ (calcd. for C20H28O5Na, 371.1834).
Neocyathin G (7). White powder; [α]D25 = −66.5 (c = 0.18, MeOH); UV (MeOH) λmax (log ε): 207 (3.49) nm; 
IR (KBr): νmax = 3369, 2933, 2870, 1648, 1046, 982 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respec-
tively; HR-ESI-MS: m/z 373.1982 [M + Na]+ (calcd. for C20H30O5Na, 373.1991).
Neocyathin H (8). Yellow oil; [α]D25 = −105.7 (c = 0.09, MeOH); UV (MeOH) λmax (log ε): 237 (3.05) nm; 
ECD: λ (c = 0.7 mg/mL, MeCN) (nm) (Δε) = 329 (−2.10), 234 (+10.4), 199 (−21.6); IR (KBr): νmax = 3417, 
2962, 2874, 1689, 1593, 1383 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respectively; HR-ESI-MS: m/z 
371.1825 [M + Na]+, (calcd. for C20H28O5Na, 371.1834).
Neocyathin I (9). White solid; [α]D25 = −47.1 (c = 0.09, MeOH); UV (MeOH) λmax (log ε): 231 (3.30) nm; IR 
(KBr): νmax = 2961, 2384, 2310, 1738, 1366, 1218 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respectively; 
HR-ESI-MS: m/z 373.1985 [M + Na]+ (calcd. for C20H30O5Na, 373.1991).
Neocyathin J (10). White powder; [α]D25 = −68.4 (c = 0.07, MeOH); UV (MeOH) λmax (log ε): 230 (3.46) nm; 
IR (KBr): νmax = 2935, 1735, 1687, 1606, 1369, 1217 cm−1; for 1H- and 13C- NMR data see Tables 1 and 2, respec-
tively; HR-ESI-MS: m/z 373.1985 [M + Na]+ (calcd. for C20H30O5Na, 373.1991).
Computational section. A preliminary conformational search was performed in Conflex6.7 using 
MMFF94s force field, according to previously reported methods33, 34. Conformers were saved and further opti-
mized using the density functional theory (DFT) method and CPCM solvent model at B3LYP/6–31 + G(d,p) level 
in Gaussian 09 software package. Frequency was calculated at the same level of theory to check optimized results. 
The four low-energy conformers with populations greater than 1% and without imaginary frequencies were sub-
mitted to ECD calculation by the TDDFT (cam-B3LYP/TZVP) method associated with CPCM solvent model in 
MeCN. The excitation energies (E), oscillator strength (f), rotatory strength in velocity form (Rvel), and rotatory 
strength in length form (Rlen) of the lowest 32 excited states were calculated. ECD spectra of different conformers 
were summated in SpecDis 1.62 according to their Boltzmann-calculated distributions. The summated curve was 
adjusted +5 nm UV-shift and 0.3 ev.
Cell culture and treatment. Murine microglia cell line BV2 cells was collected from ATCC and cultured in 
DMEM including 10% fetal bovine serum (FBS). Lipopolysaccharide (LPS) (Sigma, USA) were dissolved in PBS 
at a concentration of 1 mg/mL, while Aβ1–42 (GL Biochem (Shanghai) Ltd, China) was dissolved in 1% NH3·H2O 
at the concentration of 2 mM and incubated at 37 °C for 7 days to allow fibril formation. For biological assays, BV2 
cells were pretreated with all compounds at 50 μM for 1 h, and then stimulated with 0.5 μg/mL LPS and 20 μM 
Aβ1–42 for 24 h in DMEM with 3% FBS.
Cell viability assay. Cell viability was measured by MTT assay. Briefly, BV2 microglia cells were seeded 
in 96-well plates overnight and treated with different concentrations of isolated compounds for 24 h or 72 h. 
After incubation and removal of culture medium, the BV2 cells were incubated with 0.5 mg/ml MTT in 
phosphate-buffered saline (PBS) for 4 h. Then the MTT was removed and resolved with 150 μL of DMSO. The 
production of purple formazan was detected for the absorbance at 570 nm on a Bio-Rad microplate reader 
(Hercules, CA, USA). The cell viability was presented as a percentage to that of controls.
Western blot analysis. After drug treatment, the cellular proteins were extracted and analyzed by Western 
blotting analysis for protein expression as previously described35. Briefly, the cellular proteins were isolated and 
subjected to electrophoresis on 10% SDS-polyacrylamide gels and transferred onto a polyvinylidenedifluoride 
(PVDF) membrane. After overnight incubation in 5% BSA in the mixture of Tris-buffered saline and Tween-20 
(TBS-T), the membranes were probed with primary antibodies: iNOS (Mouse monoclonal antibody, 1:1000, 
Abcam), COX-2 (Rabbit monoclonal antibody, 1:1000) and GAPDH (Rabbit monoclonal antibody, 1:1000) 
antibodies (Cell Signaling Technology, Boston, MA, USA) for 4 h and subsequently detected by goat anti-rabbit 
IgG-HRP conjugate secondary antibodies. The activity of peroxidase retained on the blots was measured by 




log(FBE) targeting residues log(FBE) targeting residues
11 −7.84 GLY371, TRP372,GLU377 −7.82 ARG120, TYR355
14 −8.24 GLU377 −9.31 ARG120
Table 3. Logarithms of Free Binding Energies (FBE, kcal/mol) of the Inhibitors to the Active Cavities of iNOS 
(PDBcode: 3E7G) and COX-2 (PDB code: 1CX2), and Targeting Residues with Hydrogen Bonding to the 
Inhibitors in the Binding Site Located on the Mobile Flap.
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Assay for iNOS enzyme activity. The activity of iNOS enzyme was measured by using nitric oxide syn-
thase activity assay kit (Abcam, Cambridge, UK) following the manufacturer’s instruction. In brief, after drug 
treatment, the cells were harvested and washed by cold PBS. The cells were resuspended in cold NOS assay 
buffer containing protease inhibitor on ice. After pipetting up and down, the samples were centrifuged at 4 °C 
at 10000 × g for 10 min. The supernatants were collected and subjected to the measurement of the protein con-
centration using a BCA protein assay kit. Sixty microliters of 100 μg protein sample and 45 μL of reaction mix 
including diluted NOS cofactor 1, NOS cofactor 2 (1X), NOS substrate and nitrate reductase were added into each 
well, mixed well and incubated for 1 h at 37 °C. Then, 90 μL of NOS assay buffer and 5 μL of enhancer were added 
into each well, mixed and incubated at RT for 10 min. After that, 100 μL of Griess reagent mixture were added and 
incubated at RT for 10 min. The absorbance was immediately measured on a microplate reader at OD 540 nm.
Measurement of NO production in culture medium. After drug treatment, nitrite in culture medium 
was determined to reflect NO production by using Griess reagent kit for nitrite determination (ThermoFisher 
Scientific, Waltham, MA, USA). Briefly, 150 μL culture medium, 130 μL milli-Q water and 20 μL Griess reagent 
(mixture of equal volume of N-(1-naphthyl)ethylenediamine dihydrochloride and sulfanilic acid) were added 
into 96 well plate, and incubated at room temperature for 30 min. The absorbance of samples was measured on a 
spectrophotometric microplate reader at 540 nm.
Molecular docking studies. Molecular docking simulations were performed using the software Autodock 
4.2 Vina along with AutoDock Tools (ADT 1.5.6) using the hybrid Lamarckian Genetic Algorithm (LGA) as our 
previous studies30. The three dimensional (3D) crystal structure of iNOS (PDB code: 3E7G) and COX-2 (PDB 
code: 1CX2) were obtained from the RCSB Protein Data Bank. The standard 3D structure (PDB format) of com-
pounds 11 and 14 were constructed by using the “SKETCH” option function in SYBYL-X, whose configurations 
were determined by their NOESY spectra and TDDFT ECD calculations. The cubic grid box of 44 Å size (x, y, z) 
with a spacing of 0.375 Å and grid maps were built. The docking parameters consisted of setting the population 
size to 150, the number of evaluations to 2,500,000, the number of generations to 270,000, and the number of top 
individuals that automatically survive to 20, while the number of docking run was set to 40 with other default val-
ues during each docking run. The results of the most favorable free energy of binding were chosen as the resultant 
complex structures.
Statistical analysis. The results were expressed as means ± SD. The significance was analyzed by one-way 
ANOVA with Dunnett’s test using Graphpad Prism 5 software and LSD test with IBM SPSS Statistics 19.0 soft-
ware. A p-value of < 0.05 was considered as statistically significant.
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